Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity. - Wikidata - awgldk - TriplyDB

Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.

Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.

http://www.wikidata.org/entity/Q36981396

about

Trial Watch:: Oncolytic viruses for cancer therapy Trial Watch-Oncolytic viruses and cancer therapy Classification of current anticancer immunotherapies Expression of Th17 cell population regulatory cytokines in laryngeal carcinoma - Preliminary study Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.Oncolytic Immunotherapy for Treatment of Cancer.Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma.Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.Antagonistic effects of selenium on cadmium-induced apoptosis by restoring the mitochondrial dynamic equilibrium and energy metabolism in chicken spleens.High frequency of activated NKp46(+) natural killer cells in patients with new diagnosed of latent autoimmune diabetes in adults.Calreticulin is an effective immunologic adjuvant to tumor-associated antigens.Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect.NF-kappaB: Two Sides of the Same Coin.IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma.Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses.

P2860

Q27021951-F489F4D8-EC9C-4A81-A929-1E2A9B72C507 Q28072347-7F090601-B932-430E-A43F-561C68813A1D Q35149637-FD45A8B9-29A0-4640-B64D-AAEDA23E7C85 Q36243933-953CD33E-6AC4-4F1B-81C4-2E8134277441 Q37706248-33601218-8E1D-4DCC-A2AF-4EA9F2A51485 Q38848223-A0504A2E-E0D4-4F90-9AEB-055AECE408DB Q40438006-7E6AB6A7-B998-4806-9FEE-A7FE34D54FE4 Q40695075-8C75727C-F9BC-4E76-8070-9E3506BE4BF7 Q41592828-DDE14134-4D41-4155-BE96-18306C137804 Q41704358-8A13765F-4514-403E-BB74-B6025EC2BF8F Q42376411-BE66813C-D880-48BD-86CF-E942F9F46394 Q45324119-72A1C1E5-C585-4E48-9C7A-241BE38CE39C Q47556651-2E98F2B2-D30B-4B33-8D70-1F3B6DF7895E Q52719969-5B01B5E9-F5C6-43A1-80C5-CE7413DA6A58 Q55509278-6C8A6C73-29EA-4157-9F62-2C62B0927899

P2860

Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.

http://www.wikidata.org/entity/Q36981396

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.

@en

type

label

Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.

@en

prefLabel

Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.

@en

P1433

Q36981396-31040B96-F902-4BF0-9E5C-27DC90F15E55

P1476

Q36981396-28AF2103-D530-41D9-830B-3D7EC310991A

P2093

Q36981396-2BACBFAB-BFD1-42C9-AA93-9EF8D54796C3

Q36981396-37B556A3-1367-4CB4-A709-A767A5C0C75E

Q36981396-D73860D1-7BB0-4960-B898-DED8F98BDA2E

Q36981396-E8783365-680A-474F-90A1-B52AE6CAAE1F

P2860

Q36981396-00322ECD-395A-494C-8A90-0DA3D3DE0C78

Q36981396-0929064C-1784-4919-9F6A-F36505454B5F

Q36981396-1192C0C2-091A-4A2F-B3C7-002371A0467D

Q36981396-146BC7D1-47D6-4934-BC39-DBB07F2BAEC6

Q36981396-16EC934E-BB64-4E43-B3E8-D264E9FF8327

Q36981396-1967272E-96E5-4299-8C64-084BCC08C305

Q36981396-1E84E085-38E5-4A89-B1A0-E667C10F171A

Q36981396-1EB568EF-A012-46C2-B246-A33A7FB9A1B6

Q36981396-2002FAA9-E9A9-4454-A432-1018B4BAD767

Q36981396-25066CF2-C897-4778-A212-38108E6BACA0

P304

Q36981396-0F20C6EF-3F53-4B50-8349-81DC04B7B00A

P31

Q36981396-D97DBB5C-AD4A-4714-A390-076FA64E728C

P356

Q36981396-4126692C-D90F-4F23-8A44-D1E63AA3AA44

P407

Q36981396-3D7B1301-1FE2-46A7-B3DD-22EAED5F7F5D

P433

Q36981396-1368E7BB-EA5C-49EB-AC60-790FBFF6FF61

P478

Q36981396-A5C31D01-053A-4B40-B9BF-0C5E0D458F82

P50

Q36981396-EC17DA4C-7AF1-4C97-B66C-1EB9E36F7BBF

P577

Q36981396-39AEA432-E615-4274-845A-BE2D501677B6

P5875

Q36981396-018600FA-B660-42E5-8261-DA73A9A41E1E

P698

Q36981396-D2DCEC60-06A4-4E9E-96FC-759F8262DB91

P921

Q36981396-3A1D61DE-D040-40F8-8335-A1ED17A07FBA

Q36981396-CA53C603-2E1B-4A17-9B76-016142695696

P932

Q36981396-AD57A78A-8219-4145-9A88-CD31594BA4FB

P356

JOURNAL.PONE.0067512

P1433

P1476

Oncolytic adenovirus expressin ...... l-mediated antitumor immunity.

@en

P2093

Eonju Oh

http://www.w3.org/2001/XMLSchema#string

Il-Kyu Choi

http://www.w3.org/2001/XMLSchema#string

Jaesung Kim

http://www.w3.org/2001/XMLSchema#string

Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Interleukin-12 and the regulation of innate resistance and adaptive immunity

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages

Disseminated tuberculosis in interferon gamma gene-disrupted mice

T-cell quality in memory and protection: implications for vaccine design

Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.

P304

e67512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0067512

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248397707

http://www.w3.org/2001/XMLSchema#string

P698

23844018

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3701076

http://www.w3.org/2001/XMLSchema#string